Literature DB >> 10843379

The temporal importance of TNFalpha expression in the development of diabetes.

E A Green1, R A Flavell.   

Abstract

The inflammatory cytokine tumor necrosis factor alpha (TNFalpha) has been linked to the development of several autoimmune diseases. By adapting the tetracycline-regulated gene transcription system, we generated a murine model where islet-specific expression of TNFalpha could be repressed/derepressed within 48 hr following introduction/removal of tetracycline in the drinking water. Here we describe the temporal importance of TNFalpha in diabetes development in mice expressing islet-specific B7-1 and TNFalpha. We show that the duration of TNFalpha-mediated inflammation, not the putative maturity of the immune system at the time of TNFalpha expression, determines diabetes progression. Further, we have described an interval between 21 and 25 days following initiation of TNFalpha expression where the fate of islet-reactive T cells is decided.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843379     DOI: 10.1016/s1074-7613(00)80198-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  28 in total

1.  Inducible diabetes and transgene expression in a single mouse: a tool to elucidate autoimmune mechanisms.

Authors:  David J Gould
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

Review 2.  Regulation of inflammation.

Authors:  Kathleen E Sullivan
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 3.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 4.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

6.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha.

Authors:  Jing He; Kathryn Haskins
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

8.  Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.

Authors:  Ava J Wu; Hong Hua; Sibyl H Munson; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

9.  TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes.

Authors:  Yufeng Peng; Yasmina Laouar; Ming O Li; E Allison Green; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

10.  CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines.

Authors:  O Vosters; C Beuneu; N Nagy; B Movahedi; E Aksoy; I Salmon; D Pipeleers; M Goldman; V Verhasselt
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.